December 9, 2020
Diversifying genomic medicine beyond genes
The work to improve health and health care is ongoing and ever-evolving. It takes many shapes, from streamlining delivery to improving care and pursuing inclusive medical research to help develop precision medicine for all populations. This was a key element of the Arizona Return of Actionable Variants Empirical, or RAVE, study, which brought genomic medicine to […]
Tags: biomedical ethics, Center for Individualized Medicine, clinical trials, diversity, DNA, genetics, genomics, health disparities, Iftikhar Kullo, Richard Sharp
November 30, 2020
Mayo Clinic Research in the news — 11/30/2020
Many of you may feel like it’s been a really long time since the last update, but in reality, it’s been 7 days. Thanksgiving in 2020 and the fretting related to the holiday – amplified 100-fold by COVID-19 – may have made this past week seem unusually long. But at Mayo Clinic, research has continued, […]
Tags: Andrew Badley, arthritis, breast cancer, clinical trials, COVID-19, gene varient, genetic counseling, health disparities, Kannan Ramar, Nathan Boddicker, Nathan Delafield, News of the Week
November 16, 2020
Mayo Clinic Research in the news — 11/16/2020
Our research and researchers showed up in a wide range of news stories over the last week, including potential benefits of coffee for patients with colorectal cancer, plus other related stories on racial disparities in screening, and recurrence of polyps. There is COVID-19 news you can use related to obesity, mental illness and valved masks. […]
Tags: allergies, Alzheimer's disease, antibiotic, anxiety, asthma, biomarkers, brain, cancer screening, Christopher Mackintosh, colon cancer, colon polyp, colorectal cancer
October 26, 2020
Mayo Clinic Research in the news — 10/26/2020
At Mayo Clinic, patient care is evidence-based, meaning research drives the practice of medicine. Our scientists and clinician researchers are at work across the spectrum of health and the delivery of health care, seeking better outcomes and enhanced experiences while managing the total costs of care. Curable dementia, pot and opioids, childcare during COVID-19, and […]
Tags: Alzheimer's disease, Andrew Badley, artificial intelligence, autoimmune disorder, biomarkers, cardiovascular medicine, Charles Adler, clinical research, clinical trials, COVID-19, David Knopman, dementia
October 19, 2020
Mayo Clinic Research in the news — 10/19/2020
The news media recently highlighted a range of interesting topics, featuring Mayo Clinic Research and researchers on a new way to hunt down and capture deadly brain cancer cells, MSG in food, Angelman syndrome, the connection between screen time and life expectancy, COVID-19 (of course), and much more. Read on for brief excerpts and links […]
Tags: acute myeloid leukemia, aging, Angelman syndrome, artificial intelligence, biomarkers, brain cancer, cancer, cancer research, Center for Digital Health, clinical trials, collaboration, COVID-19
October 14, 2020
Lupus: starting from the beginning may lead to better outcomes
Lupus is a chronic autoimmune disorder that causes inflammation and pain throughout the body. Most common in women (9 of 10 diagnosed cases); it attacks both joints and organs – including the skin. Lupus is not curable, but symptoms can be managed with medications. Researchers hope to learn more about lupus and identify ways to […]
Tags: Ali Duarte-Garcia, area deprivation index, Center for the Science of Health Care Delivery, Cynthia Crowson, dermatology, health disparities, health sciences research, lupus, nephrology, opioids, practice improvement, rheumatology
September 25, 2020
Mayo Clinic Research in the news — 9/25/2020
COVID-19 still is holding a spot in the headlines, and probably will for at least the next year or so. But more and more there is re-emerging interest in other health care research. In this post, you’ll find Mayo Clinic Research and research experts cited on Alzheimer’s, opioids, artificial intelligence and physician burnout, seafood and […]
Tags: Andrew Badley, artificial intelligence, big data, bile duct cancer, Bobbie Gostout, brain, cancer, cardiology, cardiovascular disease, cholangiocarcinoma, clinical research, clinical trials